Login

Fulvio Citaredo, CEO di Pierrel Spa 00:00:00

Share On Facebook Share On Twitter

di Pierrel Spa

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Developing Wealth Plans: Insights from Winthrop Partners CIO R. Brian Werner | R. Brian Werner, CIO, Winthrop Partners.
00:10:00
Senior Advisor on Retirement Strategies at BlackRock
00:10:00
focused on investing in technology startups operating in highly-regulated markets|Bradley Tusk, Managing Partner,Tusk Venture Partners
00:00:00
Sam Farres, M.D. Vascular Surgeon, Mayo Clinic
00:00:00
Innovation to Impact: Knee Outcomes for Medical Professionals-Daniel B. F. Saris, M.D., Ph.D. Orthopedic Surgeon, Mayo Clinic
00:10:00
Dominique Senequier Discusses Global Challenges and Economic Shifts with Insightful Analysis | Dominique Senequier, President, Ardian.
00:10:00
The firm is focused on early-stage digital consumer and enterprise green tech and life sciences companies|Ilya Fushman,Partner,Kleiner Perkins
00:10:00
High-Value Focus: Multi-Billion-Dollar Startups LaunchDarkly and Sourcegraph|Scott Raney,Director,Redpoint
00:10:00
Embrace Flexibility and Openness to Opportunities |Marshall A. Loeb, CEO, Eastgroup Properties Inc.
00:10:00
Debunking Common Investing Myths with Jennifer Luzzatto and Mike | Jennifer Luzzatto, President, Summit Financial Partners, Inc.
00:10:00
Proposed Changes to Public Lighting Management in the Federal District | Edison Garcia, CEO, Companhia Energetica de Brasilia.
00:10:00
Interview with Julian Andrews: Insights on Deterra Royalties and Market Strategies

© 2017 - Neuhu+